药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Misoprostol
Tixocortol
The risk or severity of adverse effects can be increased when Everolimus is combined with Tixocortol.
Misoprostol
Dinutuximab
The risk or severity of adverse effects can be increased when Everolimus is combined with Dinutuximab.
Misoprostol
Blinatumomab
The risk or severity of adverse effects can be increased when Everolimus is combined with Blinatumomab.
Misoprostol
Vedolizumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Vedolizumab.
Misoprostol
Obinutuzumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Obinutuzumab.
Misoprostol
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Everolimus is combined with Dimethyl fumarate.
Misoprostol
Teriflunomide
The risk or severity of adverse effects can be increased when Everolimus is combined with Teriflunomide.
Misoprostol
Belimumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Belimumab.
Misoprostol
Eribulin
The risk or severity of adverse effects can be increased when Everolimus is combined with Eribulin.
Misoprostol
Wortmannin
The risk or severity of adverse effects can be increased when Everolimus is combined with Wortmannin.
Misoprostol
Pralatrexate
The risk or severity of adverse effects can be increased when Everolimus is combined with Pralatrexate.
Misoprostol
Bendamustine
The risk or severity of adverse effects can be increased when Everolimus is combined with Bendamustine.
Misoprostol
Belatacept
The risk or severity of adverse effects can be increased when Everolimus is combined with Belatacept.
Misoprostol
Abetimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Abetimus.
Misoprostol
Mepolizumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Mepolizumab.
Misoprostol
Human interferon omega-1
The risk or severity of adverse effects can be increased when Everolimus is combined with Human interferon omega-1.
Misoprostol
Briakinumab
The risk or severity of adverse effects can be increased when Everolimus is combined with Briakinumab.
Misoprostol
Gallium nitrate
The risk or severity of adverse effects can be increased when Everolimus is combined with Gallium nitrate.
Misoprostol
Glatiramer
The risk or severity of adverse effects can be increased when Everolimus is combined with Glatiramer.
Misoprostol
Interferon alfa
The risk or severity of adverse effects can be increased when Everolimus is combined with Interferon alfa.